A polylactide bioresorbable scaffold eluting everolimus for treatment of coronary stenosis 5-year follow-up

Journal of the American College of Cardiology

Volumn 67, Issue 7, 2016, Pages 766-776

  Serruys, Patrick W ^a   Ormiston, John ^b   Van Geuns, Robert Jan ^c   De Bruyne, Bernard ^d   Dudek, Dariusz ^e   Christiansen, Evald ^f   Chevalier, Bernard ^g   Smits, Pieter ^h   McClean, Dougal ⁱ   Koolen, Jacques ^j   Windecker, Stephan ^k   Whitbourn, Robert ^l   Meredith, Ian ^m   Wasungu, Luc ⁿ   Ediebah, Divine ⁿ   Veldhof, Susan ⁿ   Onuma, Yoshinobu ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d OLV HOSPITAL   (Belgium)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g Jacques Cartier Hospital   (France)

^h Maasstad Hospital   (Netherlands)

ⁱ CHRISTCHURCH HOSPITAL   (New Zealand)

^j CATHARINA HOSPITAL   (Netherlands)

^k UNIVERSITY OF BERN   (Switzerland)

^l ST VINCENT S HOSPITAL   (Australia)

^m MONASH MEDICAL CENTRE   (Australia)

ⁿ ABBOTT VASCULAR   (United States)

more..

Author keywords

angiography; coronary artery disease; follow up studies; intravascular imaging; long term; optical coherence; tomography

Indexed keywords

ADVERSE OUTCOME; ARTICLE; BIORESORBABLE SCAFFOLD; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY OBSTRUCTION; EVEROLIMUS ELUTING CORONARY STENT; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESTENOSIS; AGED; BIODEGRADABLE IMPLANT; CAUSE OF DEATH; CLINICAL TRIAL; CORONARY BLOOD VESSEL; CORONARY STENOSIS; DRUG ELUTING STENT; ECHOGRAPHY; EUROPE; FEMALE; INCIDENCE; INTERVENTIONAL ULTRASONOGRAPHY; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TIME FACTOR; TISSUE SCAFFOLD; TREATMENT OUTCOME; TRENDS;

EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; POLYESTER; POLYLACTIDE;

ABSORBABLE IMPLANTS; AGED; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; EUROPE; EVEROLIMUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; POLYESTERS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; SURVIVAL RATE; TIME FACTORS; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84969565753     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.11.060     Document Type: Article

References (20)

1. Y. Onuma, and P.W. Serruys Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 123 2011 779 797
2. P.W. Serruys, J.A. Ormiston, Y. Onuma, and et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
3. Y. Onuma, P.W. Serruys, J. Gomez, et al. for the ABSORB Cohort A and B Investigators Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent Catheter Cardiovasc Interv 78 2011 3 12
4. P.W. Serruys, Y. Onuma, J.A. Ormiston, and et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes Circulation 122 2010 2301 2312
5. R. Waksman Biodegradable stents: they do their job and disappear J Invasive Cardiol 18 2006 70 74
6. P.W. Serruys, H.E. Luijten, K.J. Beatt, and et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months Circulation 77 1988 361 371
7. J.P. Lane, L.E. Perkins, A.J. Sheehy, and et al. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries J Am Coll Cardiol Intv 7 2014 688 695
8. Y. Onuma, P.W. Serruys, L.E. Perkins, and et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial Circulation 122 2010 2288 2300
9. P.W. Serruys, Y. Onuma, D. Dudek, and et al. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes J Am Coll Cardiol 58 2011 1578 1588
10. J.A. Ormiston, P.W. Serruys, Y. Onuma, and et al. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study Circ Cardiovasc Interv 5 2012 620 632
11. P.W. Serruys, B. Chevalier, D. Dudek, and et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Lancet 385 2015 43 54
12. C.M. Campos, Y. Ishibashi, J. Eggermont, and et al. Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12-18, 24-, 30-, 36- and 42-month follow-up in a porcine model Int J Cardiovasc Imaging 31 2015 471 482
13. D.E. Cutlip, S. Windecker, R. Mehran, et al. for the Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
14. P.W. Serruys, Y. Onuma, H.M. Garcia-Garcia, and et al. Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months EuroIntervention 9 2014 1271 1284
15. B.E. Claessen, M.A. Beijk, V. Legrand, and et al. Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial Circ Cardiovasc Interv 2 2009 339 347
16. P.W. Serruys, H.M. Garcia-Garcia, and Y. Onuma From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 33 2012 16 25b
17. S. Lehoux, and A. Tedgui Cellular mechanics and gene expression in blood vessels J Biomech 36 2003 631 643
18. F. Otsuka, M. Vorpahl, M. Nakano, and et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans Circulation 129 2014 211 223
19. Y. Onuma, D. Dudek, L. Thuesen, and et al. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial J Am Coll Cardiol Intv 6 2013 999 1009
20. G. Sarno, Y. Onuma, H.M. Garcia Garcia, and et al. IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process Catheter Cardiovasc Interv 75 2010 914 918